About this episode
Nadia Lovell, UBS Global Wealth Management Senior US Equity Strategist, predicts the S&P 500 Index will reach 5,000 by June of 2022. Jim O'Sullivan, TD Securities Chief US Macro Strategist, expects growth momentum to be down over the next year. Andrew Pekosz, Johns Hopkins Bloomberg School of Public Health Professor & Virologist, discusses the FDA's authorization of Pfizer and Moderna booster shots for adults in the U.S. Hugo Rogers, Deltec Bank & Trust Chief Investment Officer, says markets are facing a trifecta of tailwinds. See omnystudio.com/listener for privacy information.